Everlywell Shark Tank Net Worth (Before and After Shark Tank)

Everlywell, founded by Julia Cheek in 2015, is a digital health platform that allows individuals to perform medical tests at home. After appearing on Shark Tank in 2017, Everlywell made a deal with Lori Greiner, receiving a $1 million line of credit with 5% equity. As of 2023, Everlywell has a net worth of $2.9 billion. The company has experienced significant growth since the Shark Tank appearance, with lifetime sales reaching $65 million. They have expanded their product availability to retailers such as Walgreens, Kroger, CVS, and Target. Everlywell has also successfully raised $255.55 million from 18 investors, with a valuation of $1.3 billion as of December 2020. The company has acquired other companies, including PWNHealth and Home Access Health Corp, and rebranded as Everly Health, further increasing their value. With a focus on at-home health testing, Everlywell continues to thrive and may consider going public in the future.

Key Takeaways:

• Everlywell’s net worth is $2.9 billion as of 2023.
• Lifetime sales have reached $65 million after appearing on Shark Tank.
• Everlywell has expanded its product availability to major retailers like Walgreens, Kroger, CVS, and Target.
• The company has raised $255.55 million from 18 investors with a valuation of $1.3 billion.
• Everlywell has acquired other companies, including PWNHealth and Home Access Health Corp, and rebranded as Everly Health.

Julia Cheek’s Journey and the Founding of Everlywell

Julia Cheek is the visionary founder and CEO behind Everlywell, a groundbreaking digital health platform. With a strong background in business and a personal mission to revolutionize the way individuals access medical testing, Julia’s story is one of inspiration and success.

Before creating Everlywell in 2015, Julia had a distinguished career as a management consultant at Deloitte and held executive positions at esteemed organizations like the George W. Bush Institute and MoneyGram. However, it was her own struggle to obtain and understand lab results that ignited her passion for change. Armed with her experiences and a determination to make lab testing more accessible and convenient, Julia embarked on a journey that would shape the future of healthcare.

With Everlywell, Julia set out to empower individuals by allowing them to perform medical tests in the comfort of their own homes. The concept quickly gained traction, and within a year of its launch, Everlywell generated an impressive $2.5 million in revenue. The company expanded its offerings to include 13 different tests, and its sales grew at an astounding rate of 20% per month.

Charting a Path to Success

Julia’s appearance on Shark Tank in 2017 catapulted Everlywell into the national spotlight and opened doors to new opportunities. Securing a deal with the esteemed investor Lori Greiner, Julia gained access to a $1 million line of credit with 5% equity. This partnership not only provided additional capital but also invaluable expertise and resources to fuel Everlywell’s growth.

Today, Everlywell continues to thrive under Julia’s leadership. The company’s unwavering commitment to innovation and its focus on at-home health testing have propelled its success. With a visionary founder at the helm, Everlywell is well-positioned for future growth and may even consider going public in the coming years to further expand its reach and impact.

Everlywell’s Expansion and Success After Shark Tank

Following their appearance on Shark Tank, Everlywell experienced remarkable growth and expansion, solidifying their success in the at-home health testing market. In just two years after securing a deal with Lori Greiner, the company achieved lifetime sales of $65 million, a testament to their increasing popularity and customer trust. This success prompted Everlywell to further accelerate their growth by raising $255.55 million from 18 investors through multiple funding rounds.

The funding rounds not only provided Everlywell with the necessary capital to fuel their expansion but also contributed to their increased valuation of $1.3 billion. With this substantial financial backing, the company made strategic acquisitions to strengthen their position in the market. Notably, Everlywell acquired PWNHealth and Home Access Health Corp, forming the parent company Everly Health. These acquisitions allowed Everlywell to diversify their product offerings and expand their reach, further propelling their success.

In addition to their financial achievements and acquisitions, Everlywell expanded its product availability to major retailers such as Walgreens, Kroger, CVS, and Target. This strategic move allowed the company to tap into a broader customer base and increase their revenue streams. By leveraging the convenience and accessibility of their at-home health testing kits, Everlywell positioned themselves as a trusted brand in the retail space.

Table: Everlywell Funding Rounds and Acquisitions

Funding Rounds	Investment Amount
Seed Round (2016)	$5 million
Series A (2017)	$15 million
Series B (2018)	$50 million
Series C (2019)	$100 million
Series D (2020)	$75 million
Total Funding	$255.55 million

With their continued revenue growth, successful acquisitions, and expanding retail presence, Everlywell’s net worth has skyrocketed to $2.9 billion as of 2023. The company’s commitment to making lab testing more accessible and convenient for individuals has proven to be a winning strategy. Looking ahead, it wouldn’t be surprising to see Everlywell consider a potential initial public offering (IPO) to further capitalize on their success and take the company to new heights.

Everlywell’s Future Outlook and Potential IPO

Looking ahead, Everlywell’s future prospects appear extremely promising. With a current net worth of $2.9 billion and a track record of consistent revenue growth, the company is poised for continued success in the at-home health testing market.

Having expanded their product availability to major retailers such as Walgreens, Kroger, CVS, and Target, Everlywell has solidified its position as a leader in the industry. Additionally, strategic acquisitions, including PWNHealth and Home Access Health Corp, have further reinforced their market position and contributed to their overall growth and success.

Given their remarkable achievements and potential for further expansion, it is not surprising that there is speculation about Everlywell’s potential Initial Public Offering (IPO). With a strong foundation, a diverse product portfolio, and a clear mission to make lab testing more accessible and convenient for individuals, Everlywell could be an attractive option for investors in the coming years.